News & Updates
Filter by Specialty:
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
26 Jul 2022
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
In the treatment and prevention of recurrent yeast infection or vulvovaginal candidiasis, oteseconazole performs similarly to standard-of-care fluconazole but better as compared with placebo, as shown in the results of the phase III ultraviolet study.
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
26 Jul 2022
Atlantoaxial rotatory fixation in Kawasaki disease tied to older age, heavy weight
Patients with acute Kawasaki disease (KD) may develop a rare complication called atlantoaxial rotatory fixation (AARF), which must be taken into account if cervical symptoms present in older patients with atypical KD, suggests a study.
Atlantoaxial rotatory fixation in Kawasaki disease tied to older age, heavy weight
26 Jul 2022
Post-COVID-19 vax uveitis may be more common in Southeast Asia
COVID-19 vaccination-induced uveitis is uncommon, with cases mostly self-limiting and showing good responses to treatment with no long-term sequelae, according to a Singapore study. However, reactivation of such infections appears to occur at a higher proportion in Southeast Asia, where viral and toxoplasma infections are more common.
Post-COVID-19 vax uveitis may be more common in Southeast Asia
25 Jul 2022
Local landscape, air pollution tied to COVID-19 death risk
Urban environmental determinants of vitamin D status, such as air pollution and sun exposure, appear to be important factors in assessing the risk of mortality from COVID-19, reports a recent study.
Local landscape, air pollution tied to COVID-19 death risk
24 Jul 2022
20-µg hep B vaccine can prevent vertical transmission
Using a 20-µg dose to vaccinate children born to mothers with detectable levels of hepatitis B virus surface antigen (HBsAg) appears to avert vertical transmission, reports a recent China study.
20-µg hep B vaccine can prevent vertical transmission
23 Jul 2022
HCV treatment helps prevent cirrhosis, death in persons who inject drugs
People who inject drugs (PWID) and are receiving treatment for hepatitis C virus (HCV) show a substantial decline in liver disease and mortality, according to a study.
HCV treatment helps prevent cirrhosis, death in persons who inject drugs
22 Jul 2022
40 COVID-19 vaccines and counting: Do we still need more?
There are currently 40 approved vaccines against COVID-19, of which 11 have been granted Emergency Use Authorization by the World Health Organization. [covid19.trackvaccines.org/vaccines/approved] With over 300 other candidates in the development pipeline – over 100 of which are in clinical testing [vac-lshtm.shinyapps.io/ncov_vaccine_landscape] – are new vaccines necessary?